Table 4.
Changes in Cardiac Biomarker Levels with Treatment
Baseline | Final | % Change | ||||||
---|---|---|---|---|---|---|---|---|
Statin | Placebo | P value* |
Statin | Placebo | P value† | Statin | Placebo | |
B-type natriuretic peptide, pg/mL | 175 (36 – 472) | 66 (29 – 154) | 0.227 | 107 (34 – 173) | 67 (21 – 299) | 0.605 | −38.9% | +1.5% |
High sensitivity C-reactive protein, mg/L | 1.6 (0.6 – 4.4) | 1.9 (1.0 – 3.0) | 0.700 | 1.9 (0.5 – 5.7) | 3.4 (1.1 – 5.9) | 0.307 | +18.8% | −78.9% |
Troponin I ≥ 0.04 ng/mL, % | 8 | 21 | 0.356 | 0 | 15 | 0.511 | - | - |
Baseline p values were determined by Mann-Whitney U test, and chi-square for Troponin I.
Changes between the two groups from baseline were determined by Mann-Whitney U test, and Chi-Square for Troponin I.